| 产品编号 |
产品名称 |
序列 |
别称 |
CAS Number |
分子式 |
分子量 |
疾病类 |
包装 |
| CS9534 |
β-Amyloid (1-40), (all D AA)
|
序列
|
|
|
|
|
|
|
| Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
| CS9535 |
CSF594, β-Amyloid (1-42)
|
序列
|
|
|
|
|
|
|
| CSF594-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
| CS9536 |
Cy5, β-Amyloid (1-42)
|
序列
|
|
|
|
5152.83 |
|
|
| Cy5-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
| CS9537 |
Peptide NTMT
|
序列
|
|
|
|
|
|
|
| Gly-Cys-Gly-Val-Asn-Gln-Arg-Val-Gly-Cys [Disulfide bond: Cys2 to Cys10] |
| CS9538 |
[Lys12(Cys(Palm)] Exendin-4
|
序列
|
|
|
|
|
|
|
| His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys[Cys(Palm)]-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys(PEG-5K)-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| CS9539 |
NOTA-3P-TATE-RGD
|
序列
|
|
|
|
|
|
|
| NOTA-(Bn-p-SCN)-PEG4-Glu{PEG4-Cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]-PEG4-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr (Disulfide bond CysCys) |
| CS9543 |
Des His1, Exendin-4
|
序列
|
|
|
C178H275N47O59S |
4049.68 |
|
|
| Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| CS9544 |
Phe1, Trp4, Lys(Dde)5, Octreotate
|
序列
|
|
|
C59H76N10O14S2 |
1213.4 |
|
|
| Phe-Cys-Tyr-Trp-Lys(Dde)-Thr-Cys-Thr (Disulfide bond Cys2/Cys7) |
| CS9545 |
Goserelin, Acetate
|
序列
|
|
145781-92-6 |
C59H89N19O13S |
1304.52 |
|
|
| (D-Arg)-Arg-Pro-Hyp-Gly-Thi-Ser-(D-Tic)-Oic-Arg |
| CS9546 |
Glu13, Exendin-4
|
序列
|
|
|
C184H281N49O61S |
4187.81 |
|
|
| His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Glu-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| CS9550 |
Arg28(γ-Glu-palmitoyl), Liraglutide
|
序列
|
|
|
C193H302N44O55 |
3939.02 |
|
|
| His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg(γ-Glu-palmitoyl)-Gly-Arg-Gly |
| CS9551 |
Arg30(γ-Glu-palmitoyl), Liraglutide
|
序列
|
|
|
C193H302N44O55 |
3939.02 |
|
|
| His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg(γ-Glu-palmitoyl)-Gly |
| CS9553 |
Lys20, Arg30(γ-Glu-palmitoyl), Liraglutide
|
序列
|
|
|
C172H265N43O51 |
3571.38 |
|
|
| His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg(γ-Glu-palmitoyl)-Gly |
| CS9554 |
Lys40(NOTA), Exendin-4
|
序列
|
|
|
|
4600.22 |
|
|
| His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-Lys(NOTA)-NH2 |
| CS9555 |
Lys40(DOTA), Exendin-4
|
序列
|
|
|
|
4701.45 |
|
|
| His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-Lys(DOTA)-NH2 |
| CS9556 |
(D-Ser)4, Triptorelin
|
序列
|
|
102992-39-2 |
C64H82N18O13 |
1311.45 |
|
|
| Glp-His-Trp-(D-Ser)-Tyr-(D-Trp)-Leu-Arg-Pro-Gly-NH2 |
| CS9557 |
(D-Tyr)5, Triptorelin
|
序列
|
|
321709-35-7 |
C64H82N18O13 |
1311.45 |
|
|
| Glp-His-Trp-Ser-(D-Tyr)-(D-Trp)-Leu-Arg-Pro-Gly-NH2 |
| CS9558 |
Triptorelin acid
|
序列
|
|
|
C65H82N17O14 |
1312.5 |
|
|
| Glp-His-Trp-Ser-Tyr-(D-Trp)-Leu-Arg-Pro-Gly |
| CS9559 |
Glu1, Triptorelin
|
序列
|
|
|
C64H84N18O14 |
1329.4 |
|
|
| Glu-His-Trp-Ser-Tyr-(D-Trp)-Leu-Arg-Pro-Gly-NH2 |
| CS9560 |
JR11
|
序列
|
|
|
|
1303.82 |
|
|
| Cpa-(D-Cys)-[Aph(Hor)]-[D-Aph(Cbm)]-Lys-Thr-Cys-(D-Tyr)-NH2 [Disulfide bond (D-Cys)2/Cys7] |
沪公网安备 31011502005552号
沪ICP备13005633号-1